December 2019 PMID 31774948

Monoclonal Antibody Therapy for Ebola Virus Disease.

Myron M Levine

Download social card

Mentions

Peak: 12 in Nov 2019

across 5 sources since Nov 2019

Extended reach

103,791

potential audience

Total likes

Video views

5,267

Mentions per month

Nov 2019 – Nov 2021

Where it's discussed

X / Twitter29 posts
News21 articles
Facebook4 posts
Reddit2 posts
YouTube1 videos

AI synopsis

What people are saying

The overall discussions reflect a positive yet cautious perception of the study, with comments highlighting the importance of recent clinical trials and the potential of monoclonal antibody therapies for Ebola. The tone varies from hopeful comments like 'reasons for hope' to more skeptical questions about the results' shock value, indicating a mix of curiosity and critical evaluation.

AgreementModerate agreement

Most discussions acknowledge the significance of the research, with some references to past trials and the potential of antibody therapies. Phrases like 'reasons for hope' and mentions of recent clinical results show general support.

InterestHigh interest

Numerous posts demonstrate curiosity about the therapy's mechanisms and implications, such as inquiries about the differences between antibody cocktails and their pros and cons, indicating active engagement with the content.

EngagementModerate engagement

Several posts delve into specific aspects of the study and related trials, including mentions of the NEJM publication, the use of monoclonal antibodies like ZMapp, and references to clinical impacts, which reflect more than surface-level interest.

ImpactModerate impact

While some posts perceive the research as promising and potentially transformative, others are more cautious, suggesting a moderate to significant impact on Ebola treatment strategies but not outright certainty of revolutionizing the field.

All mentions

First Case of 2019 Novel Coronavirus in the U.S. Explained

The 2019 novel coronavirus outbreak began in Wuhan, China, leading to the first confirmed case in the United States. This video provides insights into how the virus's mild symptoms can swiftly worsen, highlighting the…

Dr. ロッシュの分子生物学チャンネル · Feb 19, 2020 5,267 views

Samantha

@Amethyst2883 · X

America's "doctor ". Frauduci funded this study https://t.co/NPwkdRv9n2

Nov 24, 2021 · 503 followers View post →

Cheryl Amber Dotson

@GODZILLASLAYS65 · X

Monoclonal Antibody Therapy for Ebola Virus Disease | NEJM https://t.co/iISAazDMd3

Dec 11, 2020 · 1,093 followers View post →

Jones Allen

@jonesallen234 · X

@matthewherper Are the results really shocking with viewed with knowledge of how antibody therapies performed with Ebola? https://t.co/swkHLef2Ts

Oct 30, 2020 · 333 followers View post →

Jones Allen

@jonesallen234 · X

@JacobPlieth Are the results really shocking when viewed with knowledge that the same was true for these therapies with ebola https://t.co/swkHLef2Ts

Oct 30, 2020 · 1 like · 333 followers View post →

Ashish Patel

@ashish_patel83 · X

@megtirrell @SquawkCNBC Is it a single monoclonal Ab cocktail polyclonal Ab cocktail (like Regeneron) and what are the pros/cons of one over the other? https://t.co/jFemNS02f0

Oct 6, 2020 · 293 followers View post →

Krishan Maggon

@kkmaggon · X

Monoclonal Antibody Therapy for Ebola Virus Disease | NEJM https://t.co/3kGk1e2c4m https://t.co/6I1hKcvco6

May 23, 2020 · 1,001 followers View post →

Gilbert C Faure

@grip54 · X

Monoclonal Antibody Therapy for Ebola Virus Disease | NEJM | @scoopit https://t.co/3zp28Ww4Xq

May 23, 2020 · 570 followers View post →

Paziente Zero Podcast

@pazientezeropod · X

gli anticorpi monoclonali si usano per molte terapie diverse, tra cui malattie autoimmuni, cancro e patologie infettive. Un esempio "famoso" è quello di ZMapp per #Ebola, in questo articolo i risultati di recenti trial clinici https://t.co/d0528bhUV1

May 22, 2020 · 405 followers View post →

Ray Mitchell, MD,MBA ( He,Him)

@Sting64r · X

Jan 1, 2020 · 3 likes · 2,867 followers View post →

Juan E Losa. Infectólogo. HUFA. URJC. Sandoval Sur

@juanelosag · X

Monoclonal Antibody Therapy for Ebola Virus Disease | NEJM https://t.co/QdGTq2T8ZF

Dec 14, 2019 · 3 likes · 3,815 followers View post →

Carla

@carlapadelera · X

RT @sanz_guille: Reasons for hope in #Ebola #virus disease. An incredible volunteer human effort behind the results

Dec 12, 2019 · 1 share · 79 followers View post →

Krishan Maggon

@kkmaggon · X

Monoclonal Antibody Therapy for Ebola Virus Disease | NEJM https://t.co/tj9c65gH1u https://t.co/NPToraWMdy

Dec 12, 2019 · 1,001 followers View post →

Elysse Hendrick

@ElysseHendrick · X

RT @MSFsci: A Randomized, Controlled Trial of #Ebola Virus Disease Therapeutics, @MSF contributing author in @NEJM: https://t.co/yYGaGazEP0…

Dec 10, 2019 · 2 shares · 55 followers View post →

Gilbert C Faure

@grip54 · X

Monoclonal Antibody Therapy for Ebola Virus Disease | NEJM | @scoopit https://t.co/UwSKOzdsxs

Dec 10, 2019 · 570 followers View post →

Jesse James

@Jesse_JT_Ruta · X

RT @MSFsci: A Randomized, Controlled Trial of #Ebola Virus Disease Therapeutics, @MSF contributing author in @NEJM: https://t.co/yYGaGazEP0…

Dec 9, 2019 · 2 shares · 814 followers View post →

MSF Science

@MSFsci · X

A Randomized, Controlled Trial of #Ebola Virus Disease Therapeutics, @MSF contributing author in @NEJM: https://t.co/yYGaGazEP0 with Editorial: https://t.co/CDDRBmMmnC

Dec 9, 2019 · 2 shares · 17,220 followers View post →

Anesthesia Online

@AnesthOnline · X

Monoclonal Antibody Therapy for Ebola Virus Disease | NEJM https://t.co/VbWfKxDc62

Dec 6, 2019 · 6,623 followers View post →

RainyDaysAZ

@RainyDaysAZ · X

Monoclonal Antibody Therapy for Ebola Virus Disease | NEJM https://t.co/CDUoffpPA1

Nov 30, 2019 · 1,816 followers View post →

Gustavo R. Bonzón

@gustavobonzon · X

El 2019 ha sido productivo en la lucha contra el #Ebola. En primer lugar se logró la aprobación de una vacuna para los contactos de los infectados y ahora el uso de Anticuerpos Monoclonales para pacientes agudos. https://t.co/P5vmLKBPjE

Nov 29, 2019 · 6,300 followers View post →

Juliana Beltrán Sierra

@julipsb · X